Explore emerging IgA nephropathy therapies—complement and BAFF/APRIL inhibitors, targeted budesonide—and why long‑term safety data still lags. In this episode, Overcoming Access Barriers and Step-Edit ...
Quality of care (QoC) measures among patients with recurrent, papillary-only bacillus Calmette-Guérin (BCG)-experienced high-risk non-muscle invasive bladder cancer (HR-NMIBC). Real world outcomes ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
As an occupational health and safety professional deeply entrenched in academia, I often find myself immersed in research papers and academic conferences, delving into topics ranging from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results